Compare Innodata Inc (INOD) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innodata Inc vs Novartis AG — how do they compare? Innodata Inc trades at $63.24 (market cap $2.05B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 144.1× Innodata Inc's market cap, and Novartis AG pays a 3.07% dividend while Innodata Inc pays none. Which is the better fit depends on your goals.
| INOD | NVS | |
|---|---|---|
Market Cap | $2.05B | $295.37B |
Sector | Technology | Health |
52-Week High | $121.50 | $168.62 |
52-Week Low | $34.45 | $119.31 |
Enterprise Value | $1.80B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
